TREMFYA 100 mg ONEPRESS, solution for injection in a pre-filled pen pen, 1 ml
Active ingredients: Guselkumab
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injectionpen, 1 mlsous-cutanée
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- TREMFYA 100 mg ONEPRESS, solution injectable en stylo prérempli
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée
- Presentation description
- 1 stylo prérempli (OnePress) en verre de 1 mL
- Marketing authorisation holder
- JANSSEN CILAG INTERNATIONAL NV
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Psoriasis en plaque (maladie inflammatoire de la peau caractérisée par des plaques de peau morte apparaissant à certains endroits) de l'adulte, dans les cas sévères. ; JOURNAL OFFICIEL ; 31/01/19
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 22 May 2019
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67296108CIP73016075CIP133400930160756Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| GUSELKUMABsolution | 100 mg · un stylo prérempli de 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.